Jenna A. Moran

Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance‐conferring FLT3/tyrosine kinase domain/F691 mutation

Amir T. Fathi, Traci M. Blonquist, Daniela Hernandez et al. · Cancer · 2017 · 30 citations · Full text

Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial

Andrew M. Brunner, Traci M. Blonquist, Daniel J. DeAngelo et al. · The Lancet Haematology · 2019 · 30 citations · Full text

Hematological Malignancy, Oncology, Mixed-phenotype Acute Leukemia +10

A phase 1 study of the antibody‐drug conjugate brentuximab vedotin with re‐induction chemotherapy in patients with CD30‐expressing relapsed/refractory acute myeloid leukemia

Rupa Narayan, Traci M. Blonquist, Ashkan Emadi et al. · Cancer · 2019 · 28 citations · Full text

Concurrent FLT3 Inhibitor and IDH Inhibitor Therapy in Patients with Acute Myeloid Leukemia (AML)

Amir T. Fathi, Alexander E. Perl, Mark J. Levis et al. · Blood · 2020 · 13 citations

Building Specialized Nursing Practice Capacity in Bangladesh: An Educational Program to Prepare Nurses to Care for Oncology and Bone Marrow Transplant Patients in Dhaka, Bangladesh

Anne‐Marie Barron, Jenna A. Moran, Shabnam Sultana Nina et al. · Journal of Global Oncology · 2017 · 11 citations · Full text

Palliative Care, Nursing, International Nursing Collaboration +15